Publications by authors named "Matteo Silberg"

Claim this Profile
R
Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.
Hendrik Dinkel, Linus Materna, Ramona Stelmach, Stefanie Zschäbitz, Stephanie Neuberger, Matteo Silberg

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage Migration in Urological Cancers in Germany during the COVID-19 Pandemic: Fact or Fiction?
Henning Bahlburg, Henning Bahlburg, Patricia Rausch, Matteo Silberg, Karl Heinrich Tully

Urol Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Matteo Silberg, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Karl Tully

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis